Related Experiment Videos

Reversibility of acid and alkaline deoxyribonuclease deficiency in malignant tumor cells

Insights

Malignant tumor cells exhibit DNAse deficiency, but this enzymatic activity can reappear. This DNAse (deoxyribonuclease) deficiency is reversible, particularly during early tumor necrosis, suggesting a link to enzyme inhibitors.

Area of Science:

  • Biochemistry
  • Oncology
  • Histochemistry

Background:

  • Malignant tumor cells often display a deficiency in deoxyribonuclease (DNAse) activity.
  • This deficiency is thought to be a characteristic feature of cancerous cells.

Purpose of the Study:

  • To investigate the nature of DNAse deficiency in malignant tumor cells.
  • To explore the conditions under which DNAse activity can be restored.

Main Methods:

  • Utilized the histochemical lead nitrate technique for DNAse detection.
  • Examined DNAse activity under various experimental conditions, including in vitro and in vivo models.
  • Assessed the effects of specific compounds and tissue homogenates on DNAse activity.

Main Results:

  • Distinct alkaline and acid DNAse activity reappeared in necrotic tumor cells under several conditions.
  • Reactivation was observed during spontaneous and induced tumor necrosis, post-irradiation, and after compound treatment.
  • Tumor homogenate inhibited normal rat liver DNAse, while a membrane releaser did not reactivate DNAse in viable tumor cells.

Conclusions:

  • DNAse deficiency in malignant tumor cells is a reversible phenomenon.
  • The reversal of DNAse activity follows specific patterns and requires distinct reactivating factors.
  • The masking of DNAse activity is likely due to natural enzyme inhibitors, with reversal linked to early necrosis stages.

Related Concept Videos